celltrion vegzelma permission canada
Scope
Date
~
-
COVID-19
Celltrion wins COVID-19 treatment approval from Europe
South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...
Nov 15, 2021 (Gmt+09:00)
language -
Corporate governance
Celltrion makes first step in streamlining governance structure
South Korea’s pharmaceutical conglomerate Celltrion Group has made its very first step in reforming corporate governance structure by merging ...
Sep 17, 2021 (Gmt+09:00)
language -
Biosimilars
Samsung Bioepis gets nod for sale of ophthalmology biosimilar in Europe
South Korea’s biopharmaceutical company Samsung Bioepis Co. won approval from European authorities for sale of Byooviz, its ophthalmology bios...
Aug 23, 2021 (Gmt+09:00)
language -
Covid-19 treatment
Brazil gives emergency use nod for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...
Aug 13, 2021 (Gmt+09:00)
language -
COVID-19
Celltrion to enter clinical trials of new COVID-19 treatment
South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...
Aug 05, 2021 (Gmt+09:00)
language -
Pension funds
Canada’s CPPIB promotes Suyi Kim to global head of private equity
The Canada Pension Plan Investment Board (CPPIB) has named Suyi Kim, its Asia head, as the global chief of its private equity business, effective Se...
Jul 30, 2021 (Gmt+09:00)
-
Covid-19 treatment
Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...
Jul 20, 2021 (Gmt+09:00)
-
COVID-19
Celltrion’s COVID-19 treatment reduces incidence of severity by 70%
Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...
Jul 13, 2021 (Gmt+09:00)
language -
Biosimilars
Celltrion, Samsung Bioepis anticipate increased biosimilar sales in Europe
South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...
Jul 12, 2021 (Gmt+09:00)
-
Medicine
Celltrion, Mirae to take largest stake in UK biotech firm
South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...
Jun 07, 2021 (Gmt+09:00)
language -
Mobile networks
Samsung replaces Huawei in Canada as SaskTel’s 5G supplier
Samsung Electronics Co. has been selected as the sole vendor to supply 5G network equipment and solutions to Canadian telecom company SaskTel, based...
Mar 17, 2021 (Gmt+09:00)
language -
Celltrion eyes COVID-19 vaccine development
South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...
Feb 19, 2021 (Gmt+09:00)
language -
Short selling
Retail investors test Celltrion, HLB shares as Korea’s GameStop
Celltrion Inc. and HLB Inc., two leading South Korean biopharmaceutical shares, shot up on Monday as the main bourse’s key index climbed back ...
Feb 01, 2021 (Gmt+09:00)
-
COVID-19
Celltrion seeks to distribute COVID-19 treatment from mid-Jan
South Korea's Celltrion Inc. has completed second-phase clinical trials of its COVID-19 treatment and is seeking conditional approval of its distr...
Dec 29, 2020 (Gmt+09:00)
-
Pension funds
Ontario Teachers invests in Korean fried chicken brand valued at $1.7 bn
The Ontario Teachers' Pension Plan (OTPP) has agreed to invest 300 billion won ($275 million) in South Korea’s leading fried chicken brand B...
Dec 16, 2020 (Gmt+09:00)
language -
Mergers & Acquisitions
Celltrion finalizes $278mn acquisition of Takeda's primary care assets
South Korea's biopharmaceutical firm Celltrion Inc. has completed the $278 million acquisition of Takeda Pharmaceutical Company Ltd's primary care a...
Dec 01, 2020 (Gmt+09:00)
-
COVID-19
Celltrion says COVID-19 antibody kills virus within 5 days; shares surge
South Korea’s biopharmaceutical firm Celltrion Inc. can unveil an antibody treatment by around the end of the year that is able to kill the COVI...
Nov 11, 2020 (Gmt+09:00)
-
Earnings
Celltrion’s Q3 earnings beat market consensus to hit record high
South Korean biosimilar maker Celltrion Inc's operating profit topped market expectations by more than 20% in the third quarter, hitting a record high...
Nov 10, 2020 (Gmt+09:00)
-
Bio
Celltrion founder aims to raise $1 bn for healthcare startup from global funds
Seo Jung-jin, founder and chairman of South Korea’s biosimilar maker Celltrion Group, said on Oct. 6 that he is in talks with a number of global...
Oct 07, 2020 (Gmt+09:00)
-
Bio
Celltrion group tipped to exceed 1 trillion won in profit; first among bio firms
South Korea’s Celltrion Inc. and its affiliates are expected to post robust operating profits this year on the back of strong sales of Remsima a...
Sep 15, 2020 (Gmt+09:00)
-
LNG Project
Korean steelmakers to supply $100 mn worth of pipes for Canada’s largest LNG project
South Korean steelmakers POSCO and SeAH Steel Corp. will jointly supply 12,000 tons of stainless steel pipe for a liquefied natural gas project in Kit...
Sep 11, 2020 (Gmt+09:00)
-
Celltrion
Celltrion rebuts JP Morgan’s heavy downgrade; shares rebound from sharp fall
South Korea’s Celltrion Inc. on Sept. 10 rebutted J.P. Morgan’s massive downgrade of its target price for the biopharmaceutical company. T...
Sep 10, 2020 (Gmt+09:00)
-
Bio
Celltrion to co-develop pill-type autoimmune disease drug with UK startup
Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...
Aug 20, 2020 (Gmt+09:00)
-
Private equity
One Equity Partners fully exits from Celltrion with $1.8 bn in proceeds
One Equity Partners (OEP), a New York based private equity firm, unloaded its remaining shares in Celltrion Healthcare valued at approximately 31...
Jul 07, 2020 (Gmt+09:00)
-
Logistics
Canada and Dutch pension funds to launch $1 bn Korean logistics JV with ESR
Canada Pension Plan Investment Board (CPP Investments), the Netherlands’ APG and China’s logistics property developer ESR have agreed to s...
Apr 24, 2020 (Gmt+09:00)
-
Korean fund to lend $423 mn for Canada’s supertall construction
IGIS Asset Management Co. Ltd. has collected C$560 million ($423 million) from South Korean financial institutions to lend for The One building, a mix...
Sep 07, 2019 (Gmt+09:00)
-
Samsung Sec to cooperate with Canada pension fund for infrastructure deals
Samsung Securities Co. Ltd. has signed a preliminary agreement with Canadian pension scheme La Caisse de dépôt et placement du Québec (CDPQ) to cooper...
Sep 06, 2019 (Gmt+09:00)
-
[RFP] Korea Post seeks global managers for U.S., Canada real estate investment
- Deadline to submit proposal is May 30, 2016; Final selection set for July 1, 2016 Korea Post announced a request for proposal on May 23 for its u...
May 26, 2016 (Gmt+09:00)